CompletedNot Applicable

Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients

France80 participantsStarted 2021-08-16

Plain-language summary

ICU-Aw is highly prevalent (50%) among critically ill patients. Its diagnosis is usually delayed as it requires patients' awakening and collaboration to provide accurate measurement. This study aims to investigate the accuracy of an early ultrasound measurement of quadriceps shortening during neuromuscular electrical stimulation to diagnose future ICU-Aw in critically ill patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mechanical ventilation for at least 24 hours Exclusion Criteria: * Decision to withhold life-sustaining treatment * Pregnancy * Degenerative neurological pathology with disabling muscle weakness * Pace Maker * Inability to communicate * Chronic loss of autonomy described by the patient's family * Guardianship

What they're measuring

ICU-Aw diagnosis

Timeframe: In the 24 hours following extubation

Trial details

NCT IDNCT04722445

SponsorGroupe Hospitalier du Havre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-16

View on ClinicalTrials.gov More ICU Acquired Weakness trials